Access cutting-edge alveolar bone loss treatment through this clinical trial at a research site in Richmond. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Richmond location
Preparing your pre-screening questions…
Access alveolar bone loss specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alveolar bone loss treatment provided free
Check if you qualify for this alveolar bone loss clinical trial in Richmond, VA
No-Cost Study Care
Local to Richmond
Convenient for VA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Dental implants are a fixed replacement solution with reported long-term survival rates between 94-98% over 20-40 years. In order to ensure successful implant therapy, adequate bone and soft tissue as well as correct 3D positioning of the implant are required. Upon extraction of a tooth, socket width can decrease by up to 60% within six months post-extraction, with a 11-22% vertical reduction. Additionally, sinus pneumatization occurs post-extraction as the maxillary sinus expands into the empty socket due to disuse atrophy and intra-sinus air pressure, as explained by Wolff's law. This further reduces residual bone height (RBH), often resulting in posterior maxillary sites requiring supplemental procedures to prevent bone loss or to augment the bone height at the time of implant placement. However, if the bone height and width dimensions are sufficient before and after extraction - in that, even with the aforementioned loss in width and height percentages in the latter, a standard implant may still be placed in the surrounding bone, one can argue that grafting may not be necessarily done at the time of extraction. Rather, it can be tailored to the patients' needs; thus potentially reducing overall post-operative discomfort and pain.
Sponsor: Virginia Commonwealth University
Yes, this clinical trial (NCT07433322) has an active research site in Richmond, VA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for alveolar bone loss treatment options in Richmond, VA, this clinical trial (NCT07433322) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Richmond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alveolar bone loss specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all alveolar bone loss clinical trials near you to find additional studies recruiting in your area.
See all osteoporosis clinical trials recruiting in Richmond — not just this study.
Browse Osteoporosis Trials in Richmond →